TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT05428540 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06350006 — Predictive Biomarker (PRD): CLDN18 mRNA
Genes: CLDN18; UNQ778/PRO1572
Study NCT06582992 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05376189 — Predictive Biomarker (PRD): TLR2
Genes: TIL4; CD282
Study NCT04862910 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04573192 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04706143 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04706143 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06286267 — Predictive Biomarker (PRD): CCL18 mRNA
Genes: CCL18; AMAC1; DCCK1; MIP4; PARC; SCYA18
Study NCT06286267 — Safety Biomarker (SAF): T-cell specific protein RANTES
Genes: CCL5; D17S136E; SCYA5
Study NCT06286267 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-21
Genes: MIR21
Study NCT06115265 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04346277 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study NCT05915117 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05167799 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT06315699 — Predictive Biomarker (PRD): GTF2I mRNA
Genes: GTF2I; BAP135; WBSCR6
Study NCT06241339 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05362747 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06386614 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05699590 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT05699590 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT04919356 — Pharmacodynamic Biomarker (PDY): Leucine-rich repeat kinase 2
Genes: LRRK2; PARK8
Study NCT06414967 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT06436846 — Predictive Biomarker (PRD): MDM2 mRNA
Genes: MDM2
Study NCT05993065 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT05993065 — Predictive Biomarker (PRD): JAK2
Genes: JTK10
Study NCT05097170 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05991895 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT06245824 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02324712 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT02324712 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02324712 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02324712 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02324712 — Safety Biomarker (SAF): IL-6 and IL-10
Study NCT06068556 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05030597 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT06032988 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05339204 — Predictive Biomarker (PRD); Safety Biomarker (SAF): MYH11 mRNA
Genes: MYH11; KIAA0866
Study NCT05339204 — Predictive Biomarker (PRD): RUNX1 mRNA
Genes: RUNX1; AML1; CBFA2
Study NCT05339204 — Predictive Biomarker (PRD): RUNX1T1 mRNA
Genes: RUNX1T1; AML1T1; CBFA2T1; CDR; ETO; MTG8; ZMYND2
Study NCT05339204 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT06167772 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05369793 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05843747 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196
Study NCT05305976 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT06279637 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06263725 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196
Study NCT04312789 — Surrogate Endpoint (SUR): Platelet count response
Study NCT06417008 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06417008 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT06417008 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04356924 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05798819 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study NCT00961558 — Surrogate Endpoint (SUR): Sperm parameters
Study NCT05352867 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05352867 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04826029 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT05183646 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): CCR2 mRNA
Genes: CCR2; CMKBR2
Study NCT05453877 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06009861 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06009861 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT05320536 — Predictive Biomarker (PRD): OAT mRNA
Genes: OAT
Study NCT05164133 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05374291 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05374291 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02200250 — Predictive Biomarker (PRD): HGD mRNA
Genes: HGD; HGO
Study NCT05324956 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05346861 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03873428 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT03873428 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03873428 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05071911 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT04894227 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04787263 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06056401 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05193604 — Predictive Biomarker (PRD): TP53INP2 mRNA
Genes: TP53INP2; C20orf110; DOR; PINH
Study NCT05394012 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05950308 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06153394 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT06038526 — Safety Biomarker (SAF): Interleukin 1
Study NCT05638061 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04935372 — Predictive Biomarker (PRD): NMI mRNA
Genes: NMI
Study NCT06315686 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05893836 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT05893836 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT05283824 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04818489 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04818489 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study NCT04720313 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT04964557 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT05586516 — Predictive Biomarker (PRD): ENPP2 mRNA
Genes: ENPP2; ATX; PDNP2
Study NCT05470881 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04757376 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04694157 — Predictive Biomarker (PRD): TNNT1 mRNA
Genes: TNNT1; TNT
Study NCT04629976 — Monitoring Biomarker (MOI): HBV DNA
Study NCT04748445 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05752955 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05104788 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04940533 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT06247449 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00006578 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT05235776 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05402904 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT06645769 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05928624 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06130449 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study NCT06130449 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT05837507 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT05638685 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04712669 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT04712669 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT05208450 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06340776 — Predictive Biomarker (PRD): SP6 mRNA
Genes: SP6; KLF14
Study NCT05249803 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05859581 — Predictive Biomarker (PRD); Safety Biomarker (SAF): RPRM mRNA
Genes: RPRM
Study NCT06317506 — Predictive Biomarker (PRD): TRPA1 mRNA
Genes: TRPA1; ANKTM1
Study NCT04996524 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05818995 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05818995 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT05818995 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT05421091 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT05748236 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-B
Genes: AS
Study NCT04486833 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04486833 — Predictive Biomarker (PRD): TUSC2 mRNA
Genes: TUSC2; C3orf11; FUS1; LGCC; PDAP2
Study NCT04737954 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT04970433 — Predictive Biomarker (PRD): CARS1 mRNA
Genes: CARS1; CARS
Study NCT05699369 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05467605 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04570228 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT04570228 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT05335577 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05524558 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT05524558 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT05533086 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05936372 — Predictive Biomarker (PRD): DCD mRNA
Genes: DCD; AIDD; DSEP
Study NCT04770246 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT04848116 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT06008288 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06347029 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT04140474 — Predictive Biomarker (PRD): SPN mRNA
Genes: SPN; CD43
Study NCT05381181 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04884490 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05903378 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05329649 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT05851378 — Pharmacodynamic Biomarker (PDY): 2-hydroxyglutarate
Study NCT06414681 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study NCT06490367 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT04003896 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study NCT05723874 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT04659603 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT04627428 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study NCT04627428 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT06372574 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT05793424 — Predictive Biomarker (PRD): NOTCH3 mRNA
Genes: NOTCH3
Study NCT04741087 — Predictive Biomarker (PRD): AMT mRNA
Genes: AMT; GCST
Study NCT05894889 — Predictive Biomarker (PRD): CXCL13 mRNA
Genes: CXCL13; BCA1; BLC; SCYB13
Study NCT05894889 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05894889 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05894889 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05382234 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05826782 — Surrogate Endpoint (SUR): Sperm parameters
Study NCT06551818 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT05145426 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06241625 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT05311904 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06032000 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06032000 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05741229 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03317366 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT04625088 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT03743298 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04944927 — Predictive Biomarker (PRD): NR0B1 mRNA
Genes: NR0B1; AHC; DAX1
Study NCT06020768 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05981001 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05375825 — Predictive Biomarker (PRD): MTLN mRNA
Genes: MTLN; LEMP; LINC00116; MOXI; MPM; NCRNA00116; SMIM37
Study NCT05708430 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04784546 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05711719 — Pharmacodynamic Biomarker (PDY): Cyclic guanosine monophosphate
Study NCT06439433 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT05758857 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00000908 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06367335 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06102928 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05445765 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT05298163 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06105372 — Predictive Biomarker (PRD): FABP4 mRNA
Genes: FABP4
Study NCT04567420 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04567420 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT06015841 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study NCT05839236 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06183554 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT05793372 — Predictive Biomarker (PRD): PSEN1 mRNA
Genes: PSEN1; AD3; PS1; PSNL1
Study NCT05793372 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT05482594 — Predictive Biomarker (PRD): KITLG mRNA
Genes: KITLG; MGF; SCF
Study NCT05609500 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT05609500 — Predictive Biomarker (PRD): VKORC1 mRNA
Genes: VKORC1; VKOR; MSTP134; MSTP576; UNQ308/PRO351
Study NCT05451602 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT04731194 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05880160 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05880160 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05272410 — Predictive Biomarker (PRD): CPE mRNA
Genes: CPE
Study NCT05742789 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05742789 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study NCT05252182 — Predictive Biomarker (PRD): CGA mRNA
Genes: CGA
Study NCT05984511 — Predictive Biomarker (PRD): ADAM17 mRNA
Genes: ADAM17; CSVP; TACE
Study NCT05195450 — Monitoring Biomarker (MOI): HBV DNA
Study NCT05399329 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05399329 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06287983 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05522127 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00192803 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00192803 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT05980377 — Predictive Biomarker (PRD): Coagulation factor VIII
Genes: F8; F8C
Study NCT05980377 — Predictive Biomarker (PRD): F9 mRNA
Genes: F9
Study NCT05243342 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT04844372 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05740267 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05876364 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05575232 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05810103 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04739917 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT05338931 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05450887 — Predictive Biomarker (PRD): NR1H4 mRNA
Genes: NR1H4; BAR; FXR; HRR1; RIP14
Study NCT05450887 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study NCT05264298 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04968184 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05581589 — Predictive Biomarker (PRD): TACSTD2 mRNA
Genes: TACSTD2; GA733-1; M1S1; TROP2
Study NCT04914390 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT04760717 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04868331 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04725617 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04985812 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06453161 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05675475 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT05485246 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study NCT05406206 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00000647 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05264649 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04814615 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT05565794 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study NCT04947826 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04822337 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT05278065 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05161143 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT04868981 — Monitoring Biomarker (MOI): HBV DNA
Study NCT05210413 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05722613 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06251544 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06251544 — Predictive Biomarker (PRD): HTR2A mRNA
Genes: HTR2A; HTR2
Study NCT06251544 — Predictive Biomarker (PRD): IL15 mRNA
Genes: IL15
Study NCT06251544 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05362630 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05781841 — Predictive Biomarker (PRD): SOCS3 mRNA
Genes: SOCS3; CIS3; SSI3
Study NCT04744688 — Predictive Biomarker (PRD): Coagulation factor VIII
Genes: F8; F8C
Study NCT04744688 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study NCT04744688 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT06483269 — Pharmacodynamic Biomarker (PDY): Major prion protein
Genes: PRNP; ALTPRP; PRIP; PRP
Study NCT05776355 — Predictive Biomarker (PRD): KLRK1 mRNA
Genes: KLRK1; D12S2489E; NKG2D
Study NCT04649944 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05012020 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04786847 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04940572 — Predictive Biomarker (PRD): WFS1 mRNA
Genes: WFS1
Study NCT05648136 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04974944 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT04974944 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT06031181 — Predictive Biomarker (PRD): MIA mRNA
Genes: MIA
Study NCT04768426 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06158919 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06394960 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06053281 — Predictive Biomarker (PRD): GDNF mRNA
Genes: GDNF
Study NCT05008874 — Predictive Biomarker (PRD): AMN mRNA
Genes: AMN; UNQ513/PRO1028